CTI Life Sciences Fund
VC · Montreal · Canada
Stages
Investment region
Industries
Profile
CTI Life Sciences Fund is a venture capital firm based in Montreal, Canada, founded in 2006. The firm is led by a team of experienced professionals including Ken Pastor, Laurence Rulleau, Youssef Bennani, Shermaine Tilley, and Dana Matzen, who bring extensive backgrounds in finance, pharmaceutical R&D, and corporate development. CTI Life Sciences Fund distinguishes itself as a company builder, focusing on catalyzing nascent biotech ideas into scalable companies. The firm invests primarily in the life sciences and healthcare sectors, targeting companies at the pre-clinical and clinical development stages. CTI Life Sciences Fund operates with a dual-pronged investment strategy that emphasizes both long-term value creation and expedited exit timelines. The firm invests across North America and Europe, managing multiple funds with a focus on therapeutic and modality agnostic investments. Notable investments by CTI Life Sciences Fund include Thryv Therapeutics - drug discovery, Kainova Therapeutics - drug discovery, Aeovian Pharmaceuticals - mTORC1 inhibitor, Glycomine - PMM2-CDG treatment, and Oligon Therapeutics - siRNA therapeutics.
Contatti (2)
| Nome | Title | Telefono | ||
|---|---|---|---|---|
| Managing Partner | — | — | — | |
| Managing Partner | — | — | — |
Name, email and phone are partially hidden. Subscribe to see them in full.